2min read
PREVIOUS ARTICLE Weak consumer spending worries... NEXT ARTICLE Stocks to watch...

Executive Series 12 Dec 17: Viralytics (VLA) CEO & Managing Director, Dr Malcolm McColl
In this short video, Tom Piotrowski speaks with Viralytics (VLA) CEO & Managing Director, Dr Malcolm McColl about the company’s recent clinical trial results and plans for commercialisation of its CAVATAK drug.
YouTube Link: https://youtu.be/mixBVobIRd0
To view more Executive Series interviews, visit: https://www.commsec.com.au/market-news/executive-series